Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia
Lampson, Benjamin L., Kim, Haesook T., Davids, Matthew S., Abramson, Jeremy S., Freedman, Arnold S., Jacobson, Caron A., Armand, Philippe A., Joyce, Robin M., Arnason, Jon E., Rassenti, Laura Z., KippVolume:
3
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2018030221
Date:
April, 2019
File:
PDF, 989 KB
2019